Free Trial

Vaccine Headlines & M&A Put A Bid Into Equities

SNAPSHOT

Below gives key levels of markets in the second half of the Asia-Pac session:

  • Nikkei 225 up 149.35 points at 23555.9
  • ASX 200 up 31.18 points at 5890
  • Shanghai Comp. up 18.332 points at 3278.678
  • JGB 10-Yr future up 4 ticks at 151.96, yield down 0.6bp at 0.021%
  • Aussie 10-Yr future up 3.2 ticks at 99.103, yield down 3.2bp at 0.879%
  • U.S. 10-Yr future unch. at 139-19, yield up 0.16bp at 0.667%
  • WTI crude up $0.24 at $37.57, Gold up $8.33 at $1948.86
  • USD/JPY down 8 pips at Y106.08
  • ORACLE WINS BIDDING FOR TIKTOK IN U.S., AFTER MICROSOFT PROPOSAL REJECTED (WSJ)
  • ECB'S LAGARDE: EURO GAINS HAVE BLUNTED STIMULUS BOOST TO INFLATION (BBG)
  • ECB'S DE GUINDOS: ECB DOESN'T TARGET EUR , BUT IT IS AN IMPORTANT VARIABLE (RTRS)
  • ASTRAZENECA VACCINE TRIALS RESUME IN U.K. AFTER PAUSE OVER SAFETY CONCERNS (CNBC)
  • PFIZER CEO SAYS AMERICANS COULD GET COVID SHOT BEFORE YEAR-END (BBG)
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.